Adrenal corticosteroid inhibitors are a class of therapeutic drugs that are widely used to treat Cushing's syndrome and certain types of solid tumors, such as breast cancer. It exerts its effect by inhibiting the endogenous synthesis of hormones secreted by the adrenal cortex by interfering with the enzyme responsible for the steroid synthesis pathway.
This report contains market size and forecasts of Adrenal Corticosteroid Inhibitors in Global, including the following market information:
Global Adrenal Corticosteroid Inhibitors Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Adrenal Corticosteroid Inhibitors market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Osilodrostat Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Adrenal Corticosteroid Inhibitors include Novartis, Recordati and HRA Pharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Adrenal Corticosteroid Inhibitors companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Adrenal Corticosteroid Inhibitors Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Adrenal Corticosteroid Inhibitors Market Segment Percentages, by Type, 2021 (%)
Osilodrostat
Metyrapone
Global Adrenal Corticosteroid Inhibitors Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Adrenal Corticosteroid Inhibitors Market Segment Percentages, by Application, 2021 (%)
Hospitals
Home Care
Speciality Centres
Others
Global Adrenal Corticosteroid Inhibitors Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Adrenal Corticosteroid Inhibitors Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Adrenal Corticosteroid Inhibitors revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Adrenal Corticosteroid Inhibitors revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis
Recordati
HRA Pharma